Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm’s Canal Constructs

August 29, 2024

View Press Release Corporate presentation Contact us
Previous